Helix Sequencing vs 23andMe vs Nebula Genomics

Helix Sequencing vs 23andMe vs Nebula Genomics

Helix Sequencing, 23andMe, and Nebula Genomics are three of the most prominent DNA analysis services available in 2026, but they serve fundamentally different purposes. 23andMe is the largest consumer genetics company, known for FDA-approved health reports and detailed ancestry breakdowns across 2,000+ regions. Nebula Genomics offers 30x whole genome sequencing, providing the most complete raw data of any direct-to-consumer service. Helix Sequencing takes a different approach entirely: instead of requiring a new test, it accepts uploads from existing services and runs 3,550+ polygenic risk score models, 34-gene pharmacogenomics with CPIC star allele calling, and 400,000+ ClinVar variant scans — with optional AI integration via MCP server for Claude and ChatGPT.

The best service for you depends on what you are trying to learn. If you want ancestry and relative matching, 23andMe has the largest database. If you want the most complete raw genome data, Nebula delivers 30x WGS. If you already have DNA data and want the deepest health analysis with AI-powered interpretation, Helix Sequencing is purpose-built for that. This guide compares all three on the metrics that matter.

Quick Comparison

Each service occupies a distinct niche. The following sections break down who each service is best suited for and why.

When to Choose 23andMe

23andMe is the right choice if your primary interest is ancestry and genetic relatives. With over 14 million genotyped customers in its database, 23andMe has the largest relative-matching network of any consumer DNA service. Its ancestry composition report breaks down your heritage across 2,000+ regions with a level of geographic granularity that no other service matches.

23andMe also holds a unique regulatory position. It is the only direct-to-consumer DNA company with FDA authorization for specific health risk reports. Its FDA-cleared reports cover conditions including BRCA1/BRCA2-related breast cancer risk, late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease, and several pharmacogenomic markers. This FDA authorization means the accuracy and clinical validity of these specific reports has been independently reviewed by federal regulators.

Additionally, 23andMe offers carrier status reports for over 40 genetic conditions, which can be valuable for family planning. Its wellness reports cover traits like caffeine consumption, sleep movement, and muscle composition.

The trade-off is breadth of health analysis. 23andMe covers approximately 50 health predispositions and uses a genotyping chip that reads roughly 640,000 SNP positions. For many users, this is sufficient. For those seeking deeper polygenic risk analysis or comprehensive pharmacogenomics, the scope is more limited.

When to Choose Nebula Genomics

Nebula Genomics is the best option if you want the most complete raw DNA data available from a consumer service. Their 30x whole genome sequencing reads virtually all 6 billion base pairs of your DNA, compared to the 640,000 positions that a genotyping chip measures. This is a fundamentally different level of data completeness.

Whole genome sequencing captures rare variants and structural variants that genotyping chips cannot detect. If you have a family history of a rare genetic condition, or if you want the raw data available for future analysis as new discoveries are made, WGS provides the most future-proof dataset. Nebula also provides ancestry analysis derived from your complete genome, which can offer different insights than chip-based ancestry estimates.

Nebula’s privacy model uses blockchain-based access controls, giving users granular permission management over who can access their genomic data. Their reporting includes 27+ health predispositions and basic pharmacogenomics, with new reports added over time through their Nebula Explore library.

The trade-off is price and interpretation depth. Nebula’s 30x WGS costs $249–$999 depending on the plan, and while the raw data is the most complete, the number of interpreted health reports (27+) is smaller than what either 23andMe or Helix Sequencing provides. You are paying primarily for the sequencing itself, not for extensive interpretation.

When to Choose Helix Sequencing

Helix Sequencing is the right choice if you already have DNA data from another service and want the deepest possible health analysis without taking a new test. It accepts raw data uploads from 23andMe, AncestryDNA, MyHeritage, and most other consumer DNA providers. There is no saliva kit, no waiting, and no duplicate testing.

Where Helix Sequencing differs most is in the depth of health analysis. It runs 3,550+ polygenic risk score models from the PGS Catalog — the peer-reviewed repository maintained by EMBL-EBI and the University of Cambridge. This is roughly 70 times more PRS models than 23andMe’s ~50 health predispositions. Optional deep imputation using Beagle 5.5 expands your consumer chip data from ~700K to 28 million+ variants, improving the accuracy of each score.

Pharmacogenomics coverage includes 34 geneswith CPIC star allele calling — the same clinical standard used by hospitals and pharmacies. ClinVar scanning checks 400,000+ known pathogenic and likely pathogenic variants against your data. The AI integration via MCP server allows you to connect your genetic results directly to Claude or ChatGPT and ask questions in natural language.

The trade-offs are ancestry and raw data completeness. Helix provides basic ancestry estimation using 14 ancestry-informative markers, which is far less detailed than 23andMe’s 2,000+ regions. And because Helix works with existing chip data (not WGS), it cannot detect rare variants or structural variants that were never on the original chip. Helix also has the strictest privacy model: zero data retention with a SHA-256 deletion certificate, meaning your data cannot be retrieved after analysis.

Can You Use Helix With Existing DNA Data?

Yes. This is one of the most significant differences between Helix Sequencing and the other two services. If you have already taken a DNA test through 23andMe, AncestryDNA, MyHeritage, Living DNA, or most other consumer providers, you can download your raw data file and upload it directly to Helix Sequencing.

No new saliva kit is needed. No additional DNA collection. The upload process takes a few minutes, and deep imputation expands your existing chip data to 28 million+ variants before running the full analysis pipeline. This means you can get 3,550+ polygenic risk scores, pharmacogenomics, and ClinVar scanning from the DNA data you already own.

This also means Helix Sequencing is not mutually exclusive with the other services. Many users take a 23andMe test for ancestry and relative matching, then upload the same raw data to Helix for deeper health analysis. The two services complement each other rather than compete directly.

Key Differences Explained

Polygenic Risk Score Depth: 3,550+ vs ~50

The difference in PRS coverage is the single largest gap between these services. 23andMe provides approximately 50 health predisposition reports, each based on a curated set of genetic markers that have passed FDA review. These reports are clinically validated but cover a relatively small number of conditions.

Helix Sequencing runs the full PGS Catalog — over 3,550 peer-reviewed scoring models covering cardiovascular disease, cancer, diabetes, neurodegenerative conditions, autoimmune disorders, mental health, and hundreds of other traits. Each model was developed by research institutions and published in peer-reviewed journals. The trade-off is that these models have not undergone FDA review, though they are the same models being integrated into clinical practice at research hospitals worldwide.

Nebula Genomics offers 27+ health predisposition reports. While their whole genome sequencing data could theoretically support more PRS models, the current interpreted report count is the smallest of the three.

Pharmacogenomics: Clinical-Grade vs Basic

Pharmacogenomics — how your DNA affects drug metabolism — varies significantly across these services. Helix Sequencing covers 34 genes using CPIC (Clinical Pharmacogenetics Implementation Consortium) star allele calling, the same methodology used in hospital pharmacogenomic testing. This includes critical genes like CYP2D6, CYP2C19, CYP3A4, DPYD, and TPMT, with actionable drug-gene interaction reports.

23andMe covers selected pharmacogenomic genes with FDA authorization for specific markers, including CYP2C19 metabolizer status. The coverage is narrower but carries the weight of FDA review. Nebula provides basic pharmacogenomics derived from WGS data, though the interpretation depth is more limited.

AI Integration: A New Category

Helix Sequencing is currently the only DNA analysis service that offers native AI integration. The MCP (Model Context Protocol) server and JSON export format allow you to connect your genetic results directly to AI assistants like Claude and ChatGPT. This means you can ask questions like “What does my CYP2D6 status mean for my antidepressant?” or “Which of my risk scores should I discuss with my cardiologist?” and receive answers grounded in your actual genetic data.

Neither 23andMe nor Nebula Genomics currently offers this type of integration. As AI-assisted health tools become more common, this may become a more significant differentiator.

Privacy Models Compared

All three services take different approaches to data privacy. Helix Sequencing operates on a zero-retention model: your DNA file is processed and then permanently deleted, with a SHA-256 hash deletion certificate as cryptographic proof. No data is stored after analysis.

23andMe stores your genetic data and offers the ability to delete your account and data upon request. They have a detailed privacy policy covering data sharing with research partners, which users can opt out of. Their large database enables relative matching but requires data storage.

Nebula Genomics uses blockchain-based privacy controls that give users granular permissions over data access. Your data is encrypted and stored, with you controlling who can access it through their privacy framework.

Frequently Asked Questions

Key Takeaways